Cargando…
Impact of Bradyarrhythmias Requiring Pacing on Outcomes in Patients With COVID-19
Autores principales: | Vasti, Elena C., Ashland, Melanie D., O’Donnell, Christian, Rodriguez, Fatima, Wang, Paul, O’Brien, Connor G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American College of Cardiology Foundation. Published by Elsevier.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431298/ https://www.ncbi.nlm.nih.gov/pubmed/36543511 http://dx.doi.org/10.1016/j.jacep.2022.06.014 |
Ejemplares similares
-
N‐Terminal Pro‐B‐Type Natriuretic Peptide as a Biomarker for the Severity and Outcomes With COVID‐19 in a Nationwide Hospitalized Cohort
por: O’Donnell, Christian, et al.
Publicado: (2021) -
Outcomes of conduction system pacing compared to right ventricular pacing as a primary strategy for treating bradyarrhythmia: systematic review and meta-analysis
por: Abdin, Amr, et al.
Publicado: (2021) -
Phenytoin induced sinoatrial bradyarrhythmia in the perioperative period
por: Kakkar, Aanchal, et al.
Publicado: (2013) -
Cardiac lymphoma presenting as bradyarrhythmia
por: Sanders, Mason, et al.
Publicado: (2022) -
Bradyarrhythmias in patients with COVID-19: A case series
por: Gupta, Mohit D., et al.
Publicado: (2020)